WO2008014054A3 - Compositions à base de variantes de bmp-7, procédés et utilisations - Google Patents

Compositions à base de variantes de bmp-7, procédés et utilisations Download PDF

Info

Publication number
WO2008014054A3
WO2008014054A3 PCT/US2007/070584 US2007070584W WO2008014054A3 WO 2008014054 A3 WO2008014054 A3 WO 2008014054A3 US 2007070584 W US2007070584 W US 2007070584W WO 2008014054 A3 WO2008014054 A3 WO 2008014054A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
bmp
variant compositions
peptide chains
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/070584
Other languages
English (en)
Other versions
WO2008014054A2 (fr
Inventor
Bernard Amegadzie
Mark R Cunningham
Haimanti Dorai
Jeffrey Luo
Juliane Mills
Bethany Swencki-Underwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Priority to JP2009521874A priority Critical patent/JP2009544325A/ja
Priority to EP07798210A priority patent/EP2056852A4/fr
Publication of WO2008014054A2 publication Critical patent/WO2008014054A2/fr
Anticipated expiration legal-status Critical
Publication of WO2008014054A3 publication Critical patent/WO2008014054A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des chaînes de peptides de variantes de hBMP-7 (Human Bone Morphogenic Protein), des acides nucléiques codant ces chaînes de peptides, ainsi que des procédés de fabrication et d'utilisation de ces chaînes de peptides.
PCT/US2007/070584 2006-07-27 2007-06-07 Compositions à base de variantes de bmp-7, procédés et utilisations Ceased WO2008014054A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2009521874A JP2009544325A (ja) 2006-07-27 2007-06-07 Ｂｍｐ−７変異体組成物、方法および使用
EP07798210A EP2056852A4 (fr) 2006-07-27 2007-06-07 Compositions à base de variantes de bmp-7, procédés et utilisations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82053806P 2006-07-27 2006-07-27
US60/820,538 2006-07-27

Publications (2)

Publication Number Publication Date
WO2008014054A2 WO2008014054A2 (fr) 2008-01-31
WO2008014054A3 true WO2008014054A3 (fr) 2009-04-09

Family

ID=38982164

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/070584 Ceased WO2008014054A2 (fr) 2006-07-27 2007-06-07 Compositions à base de variantes de bmp-7, procédés et utilisations

Country Status (3)

Country Link
EP (1) EP2056852A4 (fr)
JP (1) JP2009544325A (fr)
WO (1) WO2008014054A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101274930B1 (ko) * 2011-06-03 2013-06-17 전남대학교산학협력단 골 형성 또는 혈관신생 촉진용 펩타이드 ｂｆｐ 4 및 이의 용도
KR101279145B1 (ko) * 2012-08-10 2013-06-26 주식회사 셀루메드 활성형 ｂｍｐ7의 생산율 증가 방법
GB201412290D0 (en) 2014-07-10 2014-08-27 Cambridge Entpr Ltd Novel use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5641649A (en) * 1992-01-27 1997-06-24 Italian Ministry For Universities And Scientific And Technological Research Expression of osteogenic factor OP-1 in cells of spodoptera frugiperda infected with recombinant baculovirus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE287949T1 (de) * 1992-07-31 2005-02-15 Stryker Corp Löslicher komplex morphogener proteine und zusammensetzungen davon
ATE375363T1 (de) * 1997-07-14 2007-10-15 Bolder Biotechnology Inc Derivate des wachstumshormons und verwandte proteine
US20030170213A1 (en) * 1998-01-23 2003-09-11 Marc F. Charette Methods and compositions for enhancing cognitive function using morphogenic proteins
US6677432B1 (en) * 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins
US7610156B2 (en) * 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
US7459527B2 (en) * 2004-03-31 2008-12-02 Xencor, Inc. BMP-7 variants with improved properties
WO2007087053A2 (fr) * 2005-12-22 2007-08-02 Centocor, Inc Compositions à base de variantes de bmp-7, procédés et utilisations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5641649A (en) * 1992-01-27 1997-06-24 Italian Ministry For Universities And Scientific And Technological Research Expression of osteogenic factor OP-1 in cells of spodoptera frugiperda infected with recombinant baculovirus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2056852A4 *

Also Published As

Publication number Publication date
WO2008014054A2 (fr) 2008-01-31
EP2056852A4 (fr) 2010-01-13
EP2056852A2 (fr) 2009-05-13
JP2009544325A (ja) 2009-12-17

Similar Documents

Publication Publication Date Title
WO2003011115A3 (fr) Agents de contraste multimères ciblés à base de peptides
WO2007044026A3 (fr) Compositions comportant du collagène modifié et leurs utilisations
WO2004092215A3 (fr) Methodes therapeutiques utilisant des agents liants specifiques de l'angiopoietine-2 humaine
WO2008060705A3 (fr) Anticorps anti-dll4 et leurs procédés d'utilisation
WO2006127757A3 (fr) Fusion interferon-igg
WO2005121331A3 (fr) Polypeptides galnact2 tronques et acides nucleiques
WO2010142551A8 (fr) Séquences d'acides aminés dirigées contres les récepteurs des cytokines appartenant à la famille il-17
WO2007035716A3 (fr) Compositions de proteines rap specifiques des proteines contenant du cr, et leurs utilisations
WO2004087874A3 (fr) Acides nucleiques et polypeptides
WO2007087053A3 (fr) Compositions à base de variantes de bmp-7, procédés et utilisations
WO2004011605A3 (fr) Procedes de production de proteines hybrides et compositions
EP1904090A4 (fr) Formulation de proteines de morphogenese osseuse
WO2003070904A3 (fr) Ribonuclease iii humaine, compositions et utilisations
WO2005049806A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2008014054A3 (fr) Compositions à base de variantes de bmp-7, procédés et utilisations
WO2006047728A3 (fr) Genes bmp et proteines de fusion
WO2007045019A3 (fr) Polyoleosines
WO2003093419A3 (fr) Prevention de lymphoedeme secondaire avec un adn de vegf-d
WO2004078142A3 (fr) Compositions et methodes de preventions et de traitement de maladies et d'etats pathologiques associes aux endotoxines
WO2005059101A3 (fr) Nouveau canal sodique
JO3046B1 (ar) اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها.
WO2004020457A3 (fr) Methodes et compositions permettant d'inhiber la proteine de reparation d'adn xrcc-3
WO2002053586A3 (fr) Inhibiteur de proteines d'apoptose, acides nucleiques et techniques de preparation et d'utilisation de ceux-ci
WO2004076650A3 (fr) Angiopoietine et fragments, mutants et analogues correspondants et utilisations de ceux-ci
WO2006043060A3 (fr) Proteine contenant le domaine mam

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07798210

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2009521874

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

WWE Wipo information: entry into national phase

Ref document number: 2007798210

Country of ref document: EP